Zobrazeno 1 - 10
of 547
pro vyhledávání: '"Sauser J"'
Autor:
Stritt K; Department of Urology, Lausanne University Hospital, Lausanne, Switzerland., Roth B; Department of Urology, Lausanne University Hospital, Lausanne, Switzerland.; Department of Urology, University Hospital of Bern, Inselspital, University of Bern, Bern, Switzerland., Masnada A; Department of Urology, Lausanne University Hospital, Lausanne, Switzerland., Hammann F; Division of Clinical Pharmacology & Toxicology, Department of Internal Medicine, University Hospital Bern, Bern, Switzerland., Jacot D; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Domingos-Pereira S; Urology Research Unit and Urology Biobank, Department of Urology, Lausanne University Hospital, Lausanne, Switzerland., Crettenand F; Department of Urology, Lausanne University Hospital, Lausanne, Switzerland., Bohner P; Department of Urology, Lausanne University Hospital, Lausanne, Switzerland., Sommer I; Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Bréat E; Clinical Trial Unit, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Sauser J; Clinical Trial Unit, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Derré L; Urology Research Unit and Urology Biobank, Department of Urology, Lausanne University Hospital, Lausanne, Switzerland., Haschke M; Division of Clinical Pharmacology & Toxicology, Department of Internal Medicine, University Hospital Bern, Bern, Switzerland., Collins JJ; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Institute for Medical Engineering and Scienceand, Department of Biological Engineering , Massachusetts Institute of Technology, Cambridge, MA, USA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., McKinney J; School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, 1015, Switzerland., Meylan S; Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. sylvain.meylan@chuv.ch.
Publikováno v:
Trials [Trials] 2024 Oct 15; Vol. 25 (1), pp. 682. Date of Electronic Publication: 2024 Oct 15.
Autor:
Zhou H; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Department of Hospital Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Buetti N; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Université Paris-Cité, Paris, France., Pérez-Galera S; Unidad Clínica de Medicina Interna, Hospital Universitario Virgen Macarena, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain., Bravo-Ferrer J; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain., Gutiérrez-Gutiérrez B; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Paniagua-García M; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain., Feifel J; Institute of Statistics, Ulm University, Ulm, Germany., Sauser J; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Kostyanev T; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.; National Food Institute, Technical University of Denmark, Lyngby, Denmark., Canton R; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Tan LK; Research and Development, GlaxoSmithKline, London, UK., Basoulis D; First Department of Internal Medicine, Laiko General Hospital, Athens, Greece., Pintado V; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Roilides E; Faculty of Health Sciences, Hippokration General Hospital of Thessaloniki, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Dragovac G; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Torre-Cisneros J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Departamento de Ciencias Médicas y Quirúrgicas, Servicio de Enfermedades Infecciosas Hospital Universitario Reina Sofía/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba, Córdoba, Spain., Mediç D; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey., Goossens H; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium., Bonten M; Julius Center for Health Sciences and Primary Care and University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Rodriguez-Baño J; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., De Kraker MEA; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2132-2141.
Autor:
Dalmau I Ribas M; Service Universitaire de Psychiatrie de l'Age Avancé, Département de Psychiatrie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Centre d'Investigation et de Recherche sur le Sommeil, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Sauser J; Center of Clinical Research (CRC), Training and Research Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Gillès de Pélichy E; Centre de Psychiatrie et Psychothérapie Lémanique, Morges, Switzerland., Méndez Rubio M; Service Universitaire de Psychiatrie de l'Age Avancé, Département de Psychiatrie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Schuster JP; Service Universitaire de Psychiatrie de l'Age Avancé, Département de Psychiatrie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Von Gunten A; Service Universitaire de Psychiatrie de l'Age Avancé, Département de Psychiatrie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Haba-Rubio J; Centre d'Investigation et de Recherche sur le Sommeil, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Publikováno v:
Journal of sleep research [J Sleep Res] 2024 Aug 07, pp. e14317. Date of Electronic Publication: 2024 Aug 07.
Autor:
Grant RL; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Sauser J; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Atkinson A; Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States., D'Incau S; Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Division of Infectious Diseases, Lucerne Cantonal Hospital, Lucerne, Switzerland., Buetti N; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Zanella MC; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Harbarth S; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Marschall J; Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Division of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland., Catho G; Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Division of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland.
Publikováno v:
Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 Jan; Vol. 45 (1), pp. 75-81. Date of Electronic Publication: 2023 Aug 02.
Autor:
Lenggenhager, L, Martischang, R, Sauser, J, Perez, M, Vieux, L, Graf, C, Cordey, S, Laubscher, F, Nunes, TR, Zingg, W, Cori, A, Harbarth, S, Abbas, M
Background We investigated the contribution of both occupational and community exposure for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among employees of a university-affiliated long-term care facility (LTCF), during the 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::f6befc9a5ca77c2cdf901f785f2b59ce
http://hdl.handle.net/10044/1/98033
http://hdl.handle.net/10044/1/98033
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Riccio, M E, Verschuuren, T, Conzelmann, N, Martak, D, Meunier, A, Salamanca, E, Delgado, M, Guther, J, Peter, S, Paganini, J, Martischang, R, Sauser, J, de Kraker, M E A, Cherkaoui, A, Fluit, A C, Cooper, B S, Hocquet, D, Kluytmans, J A J W, Tacconelli, E, Rodriguez-Baño, J, Harbarth, S, Brossier, Caroline, von Dach, Elodie, Renzi, Gesuele, Schrenzel, Jacques, Bunk, Stefanie, Goepel, Siri, Hölzl, Florian, Eib, Michael, Autenrieth, Ingo B, Pascual, Álvaro, Bertrand, Xavier, Scharringa, Jelle, Musicha, Patrick
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1943::58a6bebde8bbb193cf526bc64a453f6c
http://hdl.handle.net/11562/1034279
http://hdl.handle.net/11562/1034279
Autor:
Chastre J; Service de Médecine Intensive Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne University, 47-83 Bd de l'Hôpital, 75651, Paris, France. jean.chastre@gmail.com., François B; Réanimation Polyvalente and Inserm CIC 1435 & UMR 1092, CHU, Limoges, France., Bourgeois M; AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium., Komnos A; General Hospital of Larissa, Larissa, Greece., Ferrer R; SODIR-VHIR Research Group, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Rahav G; Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., De Schryver N; Clinique Saint-Pierre, Ottignies, Belgium., Lepape A; Hospices Civils de Lyon Hôpital Lyon Sud, Lyon, France., Koksal I; Faculty of Medicine, Trabzon and Acibadem University Faculty of Medicine, Karadeniz Technical University, Istanbul, Turkey., Luyt CE; Service de Médecine Intensive Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne University, 47-83 Bd de l'Hôpital, 75651, Paris, France., Sánchez-García M; Critical Care Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain., Torres A; Servei de Pneumologia, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES, ICREA, Barcelona, Spain., Eggimann P; Department of Locomotor Apparatus, Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Switzerland., Koulenti D; The University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; 2nd Critical Care Department, Attikon University Hospital, National and Kapodistrian, University of Athens, Athens, Greece., Holland TL; Duke Clinical Research Institute, Durham, NC, USA., Ali O; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA., Shoemaker K; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA.; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Ren P; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Sauser J; Infection Control Program, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland., Ruzin A; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA., Tabor DE; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA., Akhgar A; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Wu Y; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Jiang Y; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., DiGiandomenico A; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA., Colbert S; Oncology, US SM&M, AstraZeneca, Wilmington, NC, USA., Vandamme D; Inserm CIC 1435, CHU, Limoges, France., Coenjaerts F; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Malhotra-Kumar S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Timbermont L; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Oliver A; Servicio de Microbiología y Unidad de Investigación, Hospital Universitari Son Espases, Institut d'Investigació Sanitaria Illes Balears, Palma, Spain., Barraud O; INSERM U1092, Centre Hospitalier Universitaire de Limoges, Université Limoges, Limoges, France., Bellamy T; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA., Bonten M; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Science and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Goossens H; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Reisner C; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; DevPro Biopharma, Basking Ridge, NJ, USA., Esser MT; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA., Jafri HS; Clinical Research and Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca Biopharmaceuticals, One MedImmune Way, Gaithersburg, MD, 20878, USA. hasan.jafri.md@gmail.com.; Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. hasan.jafri.md@gmail.com.
Publikováno v:
Critical care (London, England) [Crit Care] 2022 Nov 15; Vol. 26 (1), pp. 355. Date of Electronic Publication: 2022 Nov 15.
Autor:
Lotfinejad N; Infection Control Programme, Faculty of Medicine, University of Geneva Hospitals, Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland. Nasimsadat.lotfinezhad@hcuge.ch.; Infection Control Programme, WHO Collaborating Centre on Infection Prevention and Control & Antimicrobial Resistance, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland. Nasimsadat.lotfinezhad@hcuge.ch., Tartari E; Infection Control Programme, WHO Collaborating Centre on Infection Prevention and Control & Antimicrobial Resistance, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Health Sciences, University of Malta, Msida, Malta., Sauser J; Infection Control Programme, Faculty of Medicine, University of Geneva Hospitals, Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland.; Infection Control Programme, WHO Collaborating Centre on Infection Prevention and Control & Antimicrobial Resistance, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland., Fankhauser-Rodriguez C; Infection Control Programme, Faculty of Medicine, University of Geneva Hospitals, Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland.; Infection Control Programme, WHO Collaborating Centre on Infection Prevention and Control & Antimicrobial Resistance, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland., Pires D; Infection Control Programme, Faculty of Medicine, University of Geneva Hospitals, Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland., Pittet D; Infection Control Programme, Faculty of Medicine, University of Geneva Hospitals, Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland.; Infection Control Programme, WHO Collaborating Centre on Infection Prevention and Control & Antimicrobial Resistance, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Publikováno v:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Oct 26; Vol. 11 (1), pp. 127. Date of Electronic Publication: 2022 Oct 26.
Autor:
Catho G; Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: gaud.catho@hcuge.ch., Sauser J; Division of Infection Control, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Coray V; Division of Clinical Informatics, Ente Ospdaliero Cantonale, Bellinzona, Switzerland., Da Silva S; Division of Informatics, Geneva University Hospital, Geneva, Switzerland., Elzi L; Division of Infectious Diseases, Ospedale San Giovanni, Ente Ospdaliero Cantonale, Bellinzona, Switzerland., Harbarth S; Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland; Division of Infection Control, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Kaiser L; Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Marti C; Division of Internal Medicine, Geneva University Hospital, Geneva, Switzerland., Meyer R; Division of Informatics, Geneva University Hospital, Geneva, Switzerland., Pagnamenta F; Division of Clinical Informatics, Ente Ospdaliero Cantonale, Bellinzona, Switzerland., Portela J; Division of Informatics, Geneva University Hospital, Geneva, Switzerland., Prendki V; Division of Geriatrics, Geneva University Hospital, Geneva, Switzerland., Ranzani A; Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Centemero NS; Division of Clinical Informatics, Ente Ospdaliero Cantonale, Bellinzona, Switzerland., Stirnemann J; Division of Internal Medicine, Geneva University Hospital, Geneva, Switzerland., Valotti R; Division of Infectious Diseases, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale and University of Southern Switzerland, Lugano, Switzerland., Vernaz N; Medical Directorate, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Suter BW; Division of Clinical Informatics, Ente Ospdaliero Cantonale, Bellinzona, Switzerland., Bernasconi E; Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland; Division of Infectious Diseases, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale and University of Southern Switzerland, Lugano, Switzerland., Huttner BD; Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Oct; Vol. 22 (10), pp. 1493-1502. Date of Electronic Publication: 2022 Jul 20.